Harvey L Bumpers1, Talaat Tadros2, Sheryl Gabram-Mendola3, Monica Rizzo3, Mersadies Martin4, Nicole Zaremba4, Joel Okoli5. 1. Department of Surgery, College of Human Medicine, Michigan State University, 1200 E. Michigan Avenue, Suite 655, Lansing, MI 48912, USA. Electronic address: harvey.bumpers@hc.msu.edu. 2. Department of Pathology Emory University School of Medicine, Atlanta, GA, USA; Avon Breast Center, Grady Memorial Hospital, Atlanta, GA, USA. 3. Avon Breast Center, Grady Memorial Hospital, Atlanta, GA, USA; Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA. 4. Department of Surgery, College of Human Medicine, Michigan State University, 1200 E. Michigan Avenue, Suite 655, Lansing, MI 48912, USA. 5. Avon Breast Center, Grady Memorial Hospital, Atlanta, GA, USA; Department of Surgery, Morehouse School of Medicine, Atlanta, GA, USA.
Abstract
BACKGROUND: Phyllodes is a rare tumor accounting for less than 1% of all breast neoplasms. Studies defining clinical predictors of malignant phyllodes (MP) are rare and inconsistent. Furthermore, MP occurrence in African American (AA) women has never been analyzed. This study will delineate clinical and pathologic features in AA patients that may reasonably predict the probability of malignancy. METHODS: A retrospective study of clinical records was carried out for 50 AA patients diagnosed with phyllodes tumors (PT) and treated between 1982 and 2012. Patients' charts were analyzed regarding demographics, pathology findings, and treatment. RESULTS: The diagnosis of benign disease was made in 40 (78%), borderline in 3 (6%), and malignancy in 7 (14%) patients; however, 1 patient (2%) had mixed phyllodes with ductal carcinoma in situ. The mean age was significantly different for patients with benign disease (33 years) compared with those with malignancy (54 years; P < .001). The average tumor size was twice as large (11.8 vs 4.1 cm; P = .029) and mitoses were higher with 50% of MPs having greater than 5 per 10 high power fields. Although rare, nodal metastasis, ulceration, and multicentric disease occurred only in MP. CONCLUSIONS: Among AA patients with phyllodes tumors, those with malignant tumors were older and had larger tumors and higher mitotic indices than those with benign disease. AA patients also displayed some of the more rare features of advanced disease and presented with malignancy near the highest reported frequency.
BACKGROUND:Phyllodes is a rare tumor accounting for less than 1% of all breast neoplasms. Studies defining clinical predictors of malignant phyllodes (MP) are rare and inconsistent. Furthermore, MP occurrence in African American (AA) women has never been analyzed. This study will delineate clinical and pathologic features in AA patients that may reasonably predict the probability of malignancy. METHODS: A retrospective study of clinical records was carried out for 50 AA patients diagnosed with phyllodes tumors (PT) and treated between 1982 and 2012. Patients' charts were analyzed regarding demographics, pathology findings, and treatment. RESULTS: The diagnosis of benign disease was made in 40 (78%), borderline in 3 (6%), and malignancy in 7 (14%) patients; however, 1 patient (2%) had mixed phyllodes with ductal carcinoma in situ. The mean age was significantly different for patients with benign disease (33 years) compared with those with malignancy (54 years; P < .001). The average tumor size was twice as large (11.8 vs 4.1 cm; P = .029) and mitoses were higher with 50% of MPs having greater than 5 per 10 high power fields. Although rare, nodal metastasis, ulceration, and multicentric disease occurred only in MP. CONCLUSIONS: Among AA patients with phyllodes tumors, those with malignant tumors were older and had larger tumors and higher mitotic indices than those with benign disease. AA patients also displayed some of the more rare features of advanced disease and presented with malignancy near the highest reported frequency.
Authors: Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan Journal: Histopathology Date: 2016-01 Impact factor: 5.087
Authors: Fresia Pareja; Felipe C Geyer; Rahul Kumar; Pier Selenica; Salvatore Piscuoglio; Charlotte K Y Ng; Kathleen A Burke; Marcia Edelweiss; Melissa P Murray; Edi Brogi; Britta Weigelt; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2017-10-12
Authors: Bruno Bisognin Garlet; Luciano Zogbi; Juliana Piveta de Lima; Paulo Pereira de Souza Favalli; Frederico Diefenthaeler Krahe Journal: Int J Surg Case Rep Date: 2019-06-05